Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells
Clinical trial NCT03644498 · COMPLETED
Trial details
- NCT number
- NCT03644498
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-05-02
- Primary completion
- 2018-10-16
- Enrollment
- 1056
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.